Organ-on-Chip Market Analysis, Share and Future Scope

Organ-on-Chip Market to Reach
$163.1 Million by 2025
Organ-on-Chip Market
Global organ-on-chip market size is forecasted to reach $163.1 million by 2025. The growth in the
market will be led by the rising need for effective drug discovery and development, increasing
demand for alternatives for animal models in research, increasing drug repurposing approaches,
and government grants and funds for research.
Explore report at:
Copyright © P&S Market Research
Organ-on-Chip Market
The organ-on-chip market has been categorized into product and services, on the basis of offering
by the market players. The products are expected to register faster growth in demand, registering
a CAGR of 43.8% during the forecast period, due to the advancement in research leading to
arrangement of newer organs cells on chips.
In terms of type, the organ-on-chip market has been categorized as liver-on-chip, lung-on-chip,
kidney-on-chip, heart-on-chip, intestine-on-chip, brain-on-chip, and others. Among these, liver-onchip held the largest share in the global organ-on-chip market, in 2017. The increasing prevalence
of chronic liver diseases, and advancement in research for its therapeutic intervention are the key
factors for the largest share of the category.
Pre-Purchase Inquiry at:
Copyright © P&S Market Research
Organ-on-Chip Market
The organ-on-chip market in APAC is expected to witness a significant growth during the forecast
period. This growth is attributed to factors such as increasing healthcare expenditure, rising
government initiatives and funding for healthcare R&D, and increase in the adoption of advanced
technologies in the region.
There are many ongoing research to determine the potential of organ-on-chip as a new platform
for biological analysis, funded by government organisations such as Chinese Academy of Sciences,
and the National Key Scientific Instrument and Equipment Development Project, China. These
factors will drive the growth of the APAC organ-on-Chip market in the future.
Copyright © P&S Market Research
Organ-on-Chip Market
The players in organ-on-chip market are launching new and innovative products to enhance their
product portfolio. For instance, in July 2017, Hmrel Corporation, launched HuRELviral application. The
Hµrelviral microliver testing platform sustains hepatitis B virus (HBV) infection in actual human liver cells
for over thirty days. This is expected to equip virologists with unprecedented insight into a drug
candidate’s potential to cure chronic HBV.
Furthermore, in February 2017, InSphero AG introduced the GravityTRAP 384 Microtissue Platform at
the Society for Laboratory Automation and Screening (SLAS) 2017 Conference. The GravityTRAP 384
platform features distinct microtissue culture and media chambers separated by a tapered SureXchange
pipetting ledge, and a continuous flat-bottomed glass base plate combined with a black-walled body,
ensuring superior confocal and high content imaging optics while reducing fluorescent cross-talk
between wells.
Copyright © P&S Market Research
Organ-on-Chip Market
Some of the other key players operating in the organ-on-chip industry include Emulate Inc., Mimetas B.V.,
TissUse GmbH, Kirkstall Ltd., CN Bio Innovations Ltd, Ascendance Biotechnology, Inc., Nortis, Inc., and
Organovo Holdings, Inc.
Request for report sample at:
Copyright © P&S Market Research
Click to edit Master title style
For queries, kindly write to:
Edit Master text styles
[email protected]
B-13, Sector-2, Noida, U.P.-201301, INDIA
Contact No: +91 120 4541 337
US/Canada Toll-Free: 1-888-778-7886
US/Canada Toll-Free: 1-888-778-7886